Testicular cancer: The perfect paradigm for marker combinations

References

• Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGC CCG) . Ann Oncol 2004;15:1377–99.
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H. Markers for testicular cancer. In: Diamandis E, Fritsche H, Lilja H, Chan D, Schwartz M, editors. Tumor markers, physiology, pathobiology, technology, and clinical applications. Washington: AACC Press; 2002. pp 351–9.
   Google Scholar
• Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242–53.
   PubMed Web of Science ®Google Scholar
• Talerman A. Germ cell tumours. Ann Pathol 1985;5:145–57.
   PubMed Web of Science ®Google Scholar
• Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments in histopathology of testicular germ cell tumors. Semin Urol 1988;6:171–88.
   Google Scholar
• Mostofi FK, Sesterhenn IA, Davis CJ Jr. Immunopathology of germ cell tumors of the testis. Semin Diagn Pathol 1987;4:320–41.
   PubMedGoogle Scholar
• Ruther U, Rothe B, Grunert K, Bader H, Sessler R, Nunnensiek C, et al. Role of human chorionic gonadotropin in patients with pure seminoma. Eur Urol 1994;26:129–33.
   PubMedGoogle Scholar
• Germa JR, Arcusa A, Casamitjana R. False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors. Cancer 1987;60:2489–93.
   Google Scholar
• de Takats PG, Jones SR, Penn R, Cullen MH. Alpha-foetoprotein heterogeneity: what is its value in managing patients with germ cell tumours? Chin Oncol 1996;8:323–6.
   Google Scholar
• Christiansen M, Hogdall CK, Andersen JR, Norgaard-Pedersen B. Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals. Scand J Clin Lab Invest 2001;61:205–15.
   Google Scholar
• Odell WD, Ross GT, Rayford PL. Radioimmunoassay for luteinizing hormone in human plasma and serum: physiological studies. J Clin Invest 1967;46:248–55.
   Google Scholar
• Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972;113:751–8.
   Google Scholar
• Hussa RO. The clinical marker hCG. New York: Praeger; 1987.
   Google Scholar
• Stenman U-H, Bidart JM, Birken S, Mann K, Nisula B, O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand J Clin Lab Invest 1993;Suppl 216:42–78.
   Google Scholar
• Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001;47:308–15.
   PubMedGoogle Scholar
• Saller B, Clara R, Spottl G, Siddle K, Mann K. Testicular cancer secretes intact human choriogonadotropin (hCG) and its free beta-subunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up. Clin Chem 1990;36:234–9.
   Google Scholar
• Madersbacher S, Klieber R, Mann K, Marth C, Tabarelli M, Wick G, et al. Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem 1992;38:370–6.
   PubMed Web of Science ®Google Scholar
• Lottersberger C, Hoermann R, Mann K, Schwarz S, Berger P. Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance. Horm Res 2003;59:125–34.
   Google Scholar
• Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003;49:144–54.
   PubMed Web of Science ®Google Scholar
• Stenman UH, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppäld M. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab 1987;64:730–6.
   Google Scholar
• Alfthan H, Haglund C, Dabek J, Stenman U-H. Concentrations of human chorionic gonadotropin, its 13-subunit and the core fragment of the 13-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38: 1981–7.
   Google Scholar
• Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, et al. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901–7.
   PubMed Web of Science ®Google Scholar
• von Eyben FE. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview. Oncodev Biol Med 1983;4:395–414.
   PubMedGoogle Scholar
• Fishman WH. Perspectives on alkaline phosphatase isoenzymes. Am J Med 1974;56:617–50.
   PubMed Web of Science ®Google Scholar
• De Broe ME, Pollet DE. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum. Clin Chem 1988;34:1995–9.
   PubMed Web of Science ®Google Scholar
• Kuzmits R, Schernthaner G, Krisch K. Serum neuron-specific enolase. A marker for responses to therapy in seminoma. Cancer 1987;60:1017–21.
   Google Scholar
• Vogelzang NJ. Prognostic factors in metastatic testicular cancer. hit J Androl 1987;10:225–37.
   Google Scholar
• International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594–603.
   PubMed Web of Science ®Google Scholar
• von Eyben FE, Blaabjerg 0, Hyltoft-Petersen P, Madsen EL, Amato R, Liu F, et al. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors. Clin Chem Lab Med 2001;39: 38–44.
   Google Scholar
• Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosh GJ. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 2001;19:2534–41.
   PubMed Web of Science ®Google Scholar
• Laguna MP, Pizzocaro G, Klepp 0, Algaba F, Kisbenedek L, Leiva 0. EAU guidelines on testicular cancer. Eur Urol 2001;40:102–10.
   Google Scholar
• Catalona WJ, Vaitukaitis JL, Fair WR. Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration. J Urol 1979;122:126–8.
   Google Scholar
• Cole LA, Rinne KM, Shahabi S, Omrani A. False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem 1999;45:313–4.
   PubMedGoogle Scholar
• Skotheim RI, Monni 0, Mousses S, Fossa SD, Kallioniemi OP, Lothe RA, et al. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 2002;62:2359–64.
   Google Scholar
• Looijenga LH, Zafarana G, Grygalewicz B, Summersgill B, Debiec-Rychter M, Veltman J, et al. Role of gain of 12p in germ cell tumour development. APMIS 2003;111:161-71; discussion 172–3.
   Google Scholar